药效评价JNJ-40255293, a novel adenosine A2A/A1 antagonist with efficacy in preclinical models of Parkinson's disease.
期刊:ACS chemical neuroscience发表年份:2014作者:John R Atack; Brian C Shook; Stefanie Rassnick; Paul F Jackson; Kenneth Rhodes; Wilhelmus H Drinkenburg; Abdallah Ahnaou; Paula Te Riele; Xavier Langlois; Brian Hrupka; Patrick De Haes; Herman Hendrickx; Nancy Aerts; Koen Hens; Annemie Wellens; Jef V
